We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$142M
Cap. Flow
+$119M
Cap. Flow %
35.99%
Top 10 Hldgs %
4.82%
Holding
913
New
440
Increased
113
Reduced
66
Closed
294

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.7M
2
SLB icon
SLB Ltd
SLB
+$1.68M
3
DAY
Dayforce
DAY
+$1.59M
4
IDA icon
Idacorp
IDA
+$1.58M
5
V icon
Visa
V
+$1.49M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$968K
2
ADM icon
Archer Daniels Midland
ADM
+$967K
3
HCA icon
HCA Healthcare
HCA
+$966K
4
ABT icon
Abbott
ABT
+$966K
5
SPGI icon
S&P Global
SPGI
+$965K

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 14.71%
3 Industrials 14.47%
4 Consumer Discretionary 11.29%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SON icon
151
Sonoco
SON
$5.8B
$680K 0.2%
+12,163
New +$660K
PAAS icon
152
Pan American Silver
PAAS
$18.6B
$675K 0.2%
+41,365
New +$619K
TRS icon
153
TriMas Corp
TRS
$1.45B
$675K 0.2%
+26,659
New +$659K
RRC icon
154
Range Resources
RRC
$8.85B
$673K 0.2%
+22,119
New +$726K
ATI icon
155
ATI
ATI
$26.3B
$671K 0.2%
14,757
+9,236
+167% +$384K
JCI icon
156
Johnson Controls International
JCI
$87.5B
$670K 0.2%
+11,623
New +$610K
FLEX icon
157
Flex
FLEX
$42.5B
$665K 0.2%
+28,976
New +$580K
FCX icon
158
Freeport-McMoran
FCX
$90.2B
$664K 0.2%
+15,606
New +$576K
SYK icon
159
Stryker
SYK
$129B
$659K 0.2%
+2,202
New +$618K
UTHR icon
160
United Therapeutics
UTHR
$26.3B
$659K 0.2%
2,997
+65
+2% +$15K
PCTY icon
161
Paylocity
PCTY
$6.97B
$658K 0.2%
3,992
+2,021
+103% +$340K
YETI icon
162
Yeti Holdings
YETI
$3.86B
$653K 0.2%
+12,612
New +$559K
DUOL icon
163
Duolingo
DUOL
$6.19B
$652K 0.2%
+2,873
New +$559K
RGEN icon
164
Repligen
RGEN
$7.39B
$651K 0.2%
3,618
+1,505
+71% +$234K
YOU icon
165
Clear Secure
YOU
$5.36B
$645K 0.19%
+31,250
New +$607K
SEM
166
DELISTED
Select Medical
SEM
$643K 0.19%
+50,810
New +$641K
DLX icon
167
Deluxe
DLX
$1.22B
$643K 0.19%
29,968
+19,760
+194% +$368K
CACI icon
168
CACI
CACI
$11B
$642K 0.19%
+1,981
New +$643K
MAA icon
169
Mid-America Apartment Communities
MAA
$15.5B
$639K 0.19%
+4,754
New +$605K
MGY icon
170
Magnolia Oil & Gas
MGY
$5.53B
$633K 0.19%
+29,750
New +$651K
ALEX
171
DELISTED
Alexander & Baldwin
ALEX
$633K 0.19%
33,294
+435
+1% +$7.35K
CWAN
172
DELISTED
Clearwater Analytics
CWAN
$633K 0.19%
+31,609
New +$623K
VZIO
173
DELISTED
VIZIO Holding Corp.
VZIO
$633K 0.19%
+82,155
New +$514K
GDOT icon
174
Green Dot
GDOT
$746M
$631K 0.19%
+63,778
New +$665K
DASH icon
175
DoorDash
DASH
$80.3B
$631K 0.19%
+6,383
New +$565K
5 6
7
8 9

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q4 2023 Portfolio in Review

As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.

  • Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
  • Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
  • Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
  • Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
  • Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
  • Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.